IRB Continued

IRB APPROVAL OF MODIFICATION
August 28, 2024
Dear Joanne D. Stekler:
On 8/28/2024, University of Washington IRB Committee J reviewed the following application:
Type of Review: Modification / Update
Title of Study: The GAIN (Greater Access and Impact with NAT) Study: Improving HIV
Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care
Nucleic Acid Tests (NATs)
Investigator: Joanne D. Stekler
STUDY ID: STUDY00010387
MOD ID: MOD00020103
Funding: Name: Centers for Disease Control and Prevention (CDC), Grant Office ID:
A142378, Funding Source ID: 6 U01 PS 005196-01-01
IND, IDE, or HDE: None
IRB Approval
Under FWA #00006878, the IRB approved modifications to your research.


Your modification(s) to the research qualified for expedited review (“minimal risk”;
Category “minor change”).

Location of documents
Use the revised consent for that was approved by the IRB. It can be downloaded from the Final
column under the Documents tab in Zipline.
Thank you for your commitment to ethical and responsible research. We wish you great success!
Sincerely,
Jenny Maki
IRB Reliance Administrator
makij2@uw.edu, 206-543-4798

4333 Brooklyn Ave. NE, Box 359470 Seattle, WA 98195-9470
main 206.543.0098 fax 206.543.9218 hsdinfo@uw.edu www.washington.edu/research/hsd
Implemented 06/25/2024 – Version 1.6 - Page 1 of 1